David Goodman-Meza, MD, PhD

Implementation Science Lead, Co-Principal Investigator

David Goodman-Meza, MD, PhD, is a Senior Research Associate at the Kirby Institute in the University of New South Wales (UNSW) in Sydney, Australia. He is a physician-scientist specialized in internal medicine, infectious diseases, and addiction medicine. He joined the Wellness Equity Alliance in July 2024. He received his MD with honors from Universidad Autonoma de Baja California in Tijuana, Mexico and a masters in clinical research at UCSD, and PhD at UNSW. His research work is focused on the relationship of substance use disorders and infectious diseases using data science, and developing interventions to improve health outcomes in this vulnerable population. He was a recipient of a U.S. NIH/NIDA Career Development Award where he trained in the use of natural language processing and machine learning to evaluate outcomes of people who inject drugs. He also lead a clinical trial in Los Angeles evaluating mobile clinical units for the treatment of opioid use disorder, HIV, primary care, and hepatitis C.